Best TWAS P=8.09e-11 · Best GWAS P=4.88e-10 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | PCGF2 | 0.14 | 0.12 | lasso | 2 | 0.12 | 6.1e-10 | 6.2 | 6.1 | 1.1e-09 | 0.98 | 0 | 1.00 | FALSE |
2 | GTEx | Adrenal Gland | PCGF2 | 0.34 | 0.09 | lasso | 6 | 0.11 | 8.5e-05 | 6.2 | 5.6 | 2.4e-08 | 0.87 | 0 | 0.98 | FALSE |
3 | GTEx | Artery Tibial | PCGF2 | 0.38 | 0.27 | lasso | 8 | 0.31 | 4.3e-25 | 6.2 | 6.0 | 2.6e-09 | 0.95 | 0 | 1.00 | FALSE |
4 | GTEx | Brain Cerebellum | PCGF2 | 0.25 | 0.29 | lasso | 3 | 0.26 | 2.4e-08 | 6.1 | -6.2 | 6.9e-10 | -0.83 | 0 | 1.00 | FALSE |
5 | GTEx | Cells Transformed fibroblasts | PCGF2 | 0.34 | 0.28 | lasso | 4 | 0.30 | 3.2e-23 | 6.2 | 5.6 | 1.8e-08 | 0.94 | 0 | 1.00 | FALSE |
6 | GTEx | Colon Transverse | PCGF2 | 0.29 | 0.21 | lasso | 5 | 0.20 | 6.2e-10 | 6.2 | 6.2 | 5.7e-10 | 1.00 | 0 | 1.00 | FALSE |
7 | GTEx | Esophagus Mucosa | PCGF2 | 0.32 | 0.24 | lasso | 7 | 0.23 | 1.8e-15 | 6.2 | 6.2 | 6.8e-10 | 0.97 | 0 | 1.00 | FALSE |
8 | GTEx | Esophagus Muscularis | PCGF2 | 0.21 | 0.15 | lasso | 8 | 0.13 | 3.3e-08 | 6.2 | 5.7 | 9.7e-09 | 0.96 | 0 | 1.00 | FALSE |
9 | GTEx | Heart Atrial Appendage | PCGF2 | 0.18 | 0.13 | lasso | 3 | 0.09 | 6.1e-05 | 6.2 | 6.2 | 7.2e-10 | 1.00 | 0 | 1.00 | FALSE |
10 | GTEx | Lung | PCGF2 | 0.25 | 0.17 | lasso | 7 | 0.17 | 4.8e-13 | 6.2 | 5.8 | 6.4e-09 | 0.97 | 0 | 1.00 | FALSE |
11 | GTEx | Pancreas | PCGF2 | 0.29 | 0.12 | lasso | 5 | 0.07 | 5.3e-04 | 6.2 | 5.9 | 3.2e-09 | 0.96 | 0 | 0.97 | FALSE |
12 | GTEx | Skin Not Sun Exposed Suprapubic | PCGF2 | 0.39 | 0.23 | lasso | 4 | 0.21 | 6.9e-12 | 6.2 | 6.2 | 6.2e-10 | 1.00 | 0 | 1.00 | FALSE |
13 | GTEx | Skin Sun Exposed Lower leg | PCGF2 | 0.36 | 0.30 | lasso | 7 | 0.32 | 1.3e-26 | 6.2 | 6.5 | 8.1e-11 | 0.97 | 0 | 1.00 | TRUE |
14 | YFS | Blood | PCGF2 | 0.03 | 0.02 | enet | 7 | 0.03 | 2.1e-11 | 6.2 | 5.7 | 1.0e-08 | 0.79 | 0 | 1.00 | FALSE |
15 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | PCGF2 | 0.14 | 0.06 | blup | 35 | 0.11 | 1.1e-09 | 6.1 | 5.6 | 2.1e-08 | 0.82 | 0 | 1.00 | FALSE |
16 | The Cancer Genome Atlas | Breast Invasive Carcinoma | PCGF2 | 0.06 | 0.06 | blup | 37 | 0.05 | 4.4e-11 | 6.2 | 6.2 | 6.7e-10 | 0.85 | 0 | 1.00 | FALSE |
17 | The Cancer Genome Atlas | Colon Adenocarcinoma | PCGF2 | 0.23 | 0.23 | lasso | 3 | 0.22 | 9.8e-13 | 6.2 | 6.2 | 5.1e-10 | 0.99 | 0 | 1.00 | FALSE |
18 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | PCGF2 | 0.13 | 0.06 | blup | 37 | 0.09 | 7.0e-10 | 6.2 | 5.4 | 5.8e-08 | 0.85 | 0 | 1.00 | FALSE |
19 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | PCGF2 | 0.24 | 0.15 | lasso | 5 | 0.18 | 2.2e-19 | 6.2 | 5.9 | 3.0e-09 | 0.93 | 0 | 1.00 | FALSE |
20 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | PCGF2 | 0.05 | 0.03 | lasso | 3 | 0.04 | 1.0e-05 | 4.5 | 5.9 | 3.7e-09 | 0.89 | 0 | 1.00 | FALSE |
21 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | CISD3 | 0.11 | 0.06 | blup | 33 | 0.04 | 1.9e-03 | 6.1 | -5.7 | 1.3e-08 | -0.78 | 0 | 0.98 | FALSE |
22 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | PCGF2 | 0.28 | 0.16 | lasso | 4 | 0.13 | 3.4e-06 | 6.2 | 6.1 | 8.0e-10 | 0.97 | 0 | 1.00 | FALSE |
23 | The Cancer Genome Atlas | Prostate Adenocarcinoma | PCGF2 | 0.18 | 0.14 | lasso | 4 | 0.16 | 2.4e-16 | 6.2 | 5.8 | 8.0e-09 | 0.94 | 0 | 1.00 | FALSE |
24 | The Cancer Genome Atlas | Stomach Adenocarcinoma | PCGF2 | 0.14 | 0.04 | enet | 8 | 0.16 | 6.8e-12 | -2.3 | 5.5 | 4.4e-08 | 0.76 | 0 | 1.00 | FALSE |
25 | The Cancer Genome Atlas | Thyroid Carcinoma | PCGF2 | 0.27 | 0.22 | enet | 9 | 0.25 | 1.4e-24 | 6.2 | 5.6 | 2.5e-08 | 0.88 | 0 | 1.00 | FALSE |